January 2012
Asian American women are at high risk for developing osteoporosis (porous bones), a disease that is preventable and treatable. Studies show that Asian Americans share many of the risk factors that apply to Caucasian women. As an Asian American woman, it is important that you understand what osteoporosis is and what steps you can take to prevent or treat it.
Osteoporosis is a condition in which the bones become less dense and more likely to fracture. If not prevented or if left untreated, bone loss can progress painlessly until a bone breaks, typically in the hip, spine, or wrist. A hip fracture can limit mobility and lead to a loss of independence, and vertebral fractures can result in a loss of height, stooped posture, and chronic pain.
Several risk factors increase your chances of developing osteoporosis, including:
Recent studies indicate a number of facts that highlight the risk that Asian American women face with regard to developing osteoporosis:
Building strong bones, especially before the age of 20, can be the best defense against developing osteoporosis. A healthy lifestyle can be critically important for keeping bones strong. To help prevent osteoporosis:
Talk to your doctor if you have a family history of osteoporosis or other factors that may put you at increased risk for the disease. Your doctor may suggest that you have your bone density measured through a safe test that can determine your risk for fractures (broken bones) and measure your response to osteoporosis treatment. The most widely recognized bone mineral density test (BMD) is called a dual-energy x-ray absorptiometry, or DXA test. The BMD test is painless, a bit like having an x-ray, but with much less exposure to radiation. It can measure bone density at your hip and spine.
Although there is no cure for osteoporosis, several medications are available for the prevention and/or treatment of osteoporosis, including: bisphosphonates; estrogen agonists/antagonists (also called selective estrogen receptor modulators or SERMS); calcitonin; parathyroid hormone; estrogen therapy; hormone therapy; and a recently approved RANK ligand (RANKL) inhibitor.
Website: http://www.bones.nih.gov
For more information on minority health, visit:
Website: www.minorityhealth.hhs.gov
This publication contains information about medications used to treat the health condition discussed here. When this publication was produced, we included the most up-to-date (accurate) information available. Occasionally, new information on medication is released.
For updates and for any questions about any medications you are taking, please contact:
Website: http://www.fda.gov/
Toll free: 888–INFO–FDA (888–463–6332)
For updates and questions about statistics, please contact:
Website: http://www.cdc.gov/nchs
Toll free: 800-232-4636
2 AMS Circle
Bethesda, MD 20892-3676
Phone: 202-223-0344
Toll Free: 800-624-BONE (2663)
TTY: 202-466-4315
Fax: 202-293-2356
Email: NIHBoneInfo@mail.nih.gov
Website: http://www.bones.nih.gov
The NIH Osteoporosis and Related Bone Diseases ~ National Resource Center provides patients, health professionals, and the public with an important link to resources and information on metabolic bone diseases. The mission of NIH ORBD~NRC is to expand awareness and enhance knowledge and understanding of the prevention, early detection, and treatment of these diseases as well as strategies for coping with them.
The NIH Osteoporosis and Related Bone Diseases ~ National Resource Center is supported by the National Institute of Arthritis and Musculoskeletal and Skin Diseases with contributions from:
The National Institutes of Health (NIH) is a component of the U.S. Department of Health and Human Services (DHHS).
Most of our bone publications are available online only. Some are available in print. Would you like to order publications on bone disorders to be mailed to you? Visit our online order form.